These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22265161)

  • 1. Genetics of hemolytic uremic syndromes.
    Malina M; Roumenina LT; Seeman T; Le Quintrec M; Dragon-Durey MA; Schaefer F; Fremeaux-Bacchi V
    Presse Med; 2012 Mar; 41(3 Pt 2):e105-14. PubMed ID: 22265161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.
    Bianchi L; Gaiani F; Vincenzi F; Kayali S; Di Mario F; Leandro G; De' Angelis GL; Ruberto C
    Acta Biomed; 2018 Dec; 89(9-S):153-157. PubMed ID: 30561409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Where are we with haemolytic uremic syndrome?
    Cavero T; Alonso M
    Med Clin (Barc); 2018 Oct; 151(8):329-335. PubMed ID: 29699703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.
    Alberti M; Valoti E; Piras R; Bresin E; Galbusera M; Tripodo C; Thaiss F; Remuzzi G; Noris M
    Am J Transplant; 2013 Aug; 13(8):2201-6. PubMed ID: 23731345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic uremic syndrome in children.
    Talarico V; Aloe M; Monzani A; Miniero R; Bona G
    Minerva Pediatr; 2016 Dec; 68(6):441-455. PubMed ID: 27768015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Epidemiology, pathophysiology and clinics].
    Rafat C; Coppo P; Fakhouri F; Frémeaux-Bacchi V; Loirat C; Zuber J; Rondeau E
    Rev Med Interne; 2017 Dec; 38(12):817-824. PubMed ID: 28711159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
    Nakayama S; Hirashio S; Yorishima H; Doi T; Yoshida Y; Matsumoto M; Masaki T
    CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli after pericardiectomy.
    Tome J; Maselli DB; Im R; Amdahl MB; Pfeifle D; Hagen C; Halland M
    Clin J Gastroenterol; 2022 Feb; 15(1):123-127. PubMed ID: 34677733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities.
    McCoy N; Weaver DJ
    BMC Pediatr; 2014 Nov; 14():278. PubMed ID: 25373393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.
    Westra D; Volokhina EB; van der Molen RG; van der Velden TJ; Jeronimus-Klaasen A; Goertz J; Gracchi V; Dorresteijn EM; Bouts AH; Keijzer-Veen MG; van Wijk JA; Bakker JA; Roos A; van den Heuvel LP; van de Kar NC
    Pediatr Nephrol; 2017 Feb; 32(2):297-309. PubMed ID: 27718086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttransplant recurrence of atypical hemolytic uremic syndrome.
    Valoti E; Alberti M; Noris M
    J Nephrol; 2012; 25(6):911-7. PubMed ID: 22760880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin associated hemolytic uremic syndrome.
    Keir LS
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):525-39. PubMed ID: 26043390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathophysiology of atypical hemolytic uremic syndrome. Ten years of progress, from laboratory to patient].
    Frémeaux-Bacchi V
    Biol Aujourdhui; 2013; 207(4):231-40. PubMed ID: 24594571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Kremer Hovinga JA; Heeb SR; Skowronska M; Schaller M
    J Thromb Haemost; 2018 Apr; 16(4):618-629. PubMed ID: 29356300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of atypical hemolytic uremic syndrome (aHUS).
    Rodríguez de Córdoba S; Hidalgo MS; Pinto S; Tortajada A
    Semin Thromb Hemost; 2014 Jun; 40(4):422-30. PubMed ID: 24799305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in our understanding of the pathogenesis of hemolytic uremic syndromes.
    Bowen EE; Coward RJ
    Am J Physiol Renal Physiol; 2018 Mar; 314(3):F454-F461. PubMed ID: 29167171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemolytic uremic syndrome in adults].
    Hertig A; Ridel C; Rondeau E
    Nephrol Ther; 2010 Jul; 6(4):258-71. PubMed ID: 20399168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombotic microangiopathies].
    Moulinier C; Veyradier A; Rondeau E; Coppo P;
    Rev Prat; 2013 Feb; 63(2):163-70. PubMed ID: 23513771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.